The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Open accessAbstract
Although CRISPR-Cas9 nucleases are widely used for genome editing, the range of sequences that Cas9 can recognize is constrained by the need for a specific protospacer adjacent motif (PAM). As a result, it can often be difficult to target double-stranded breaks (DSBs) with the precision that is necessary for various genome-editing applications. The ability to engineer Cas9 derivatives with purposefully altered PAM specificities would address this limitation. Here we show that the commonly used Streptococcus pyogenes Cas9 (SpCas9) can be modified to recognize alternative PAM sequences using structural information, bacterial selection-based directed evolution, and combinatorial design. These altered PAM specificity variants enable robust editing of endogenous gene sites in zebrafish and human cells not currently targetable by wild-type SpCas9, and their genome-wide specificities are comparable to wild-type SpCas9 as judged by GUIDE-seq analysis. In addition, we identify and characterize another SpCas9 variant that exhibits improved specificity in human cells, possessing better discrimination against off-target sites with non-canonical NAG and NGA PAMs and/or mismatched spacers. We also find that two smaller-size Cas9 orthologues, Streptococcus thermophilus Cas9 (St1Cas9) and Staphylococcus aureus Cas9 (SaCas9), function efficiently in the bacterial selection systems and in human cells, suggesting that our engineering strategies could be extended to Cas9s from other species. Our findings provide broadly useful SpCas9 variants and, more importantly, establish the feasibility of engineering a wide range of Cas9s with altered and improved PAM specificities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Precision editing of alleles in a human cell has drastically improved the understanding of genotypic and phenotypic effects in gene therapy due to the lower off-target rates [119,120,121].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides, there are other variants that could identify different PAM sequences, such as VQR, VRER, VRQR, and QQR1, allowing gene editing on a wider range of genetic loci.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The basic bacterial selection scheme performed was adapted from a previously described positive selection system for identifying Cas9 mutants in E. coli31.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“To be applicable to a wider range of genomic sites, some non-NGG PAM Cas9 were generated.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“This could result in the development of wider-ranged VQR, EQR, and VRER SpCas9 variants, enabling the targeting of NGAN, NGNG, and NGCG PAMs, respectively (Kleinstiver et al., 2015; Hirano et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Kleinstiver et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“These modifications have led to the creation of SpCas9 variants such as VQR, EQR, and VRER, which can recognize broader PAM sequences like NGAN, NGNG, and NGCG, respectively (Kleinstiver et al., 2015; Hirano et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Kleinstiver et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 genomic localization is delimited by the protospacer adjacent motif (PAM), which is NGG for SpCas9 while evolved variants of SpCas9 tolerate a broader range of PAM sequences17–21.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [18]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This screen identified four key beneficial point mutations in SpCas9, giving rise to evoCas9, a variant that exhibits fidelity exceeding SpCas9-HF1 and eSpCas9 (Kleinstiver et al., 2015; Casini et al., 2018).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Kleinstiver et al., 2015
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“SaKKHcas9 is an evolved variant of SaCas9 and recognizes the more relaxed NNNRRT PAM18.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Self-citationCRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Self-citation
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
Lau, C., Liang, Q., & Zhu, H. (2024) · Transgenic Research · doi:10.1007/s11248-024-00404-x · Cited by 19
AAV-mediated gene therapies by miniature gene editing tools
Kong, X., Li, T., & Yang, H. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2608-5 · Cited by 18
Zhang, G., Luo, Y., Xie, H., & Dai, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010945 · Cited by 20
Modeling Cancer in the CRISPR Era
Ventura, A., & Dow, L. E. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050455 · Cited by 18
Viral Vectors, Engineered Cells and the CRISPR Revolution
DiCarlo, J. E., Deeconda, A., & Tsang, S. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63904-8_1 · Cited by 19
Engineering of biomolecules by bacteriophage directed evolution
Brödel, A. K., Isalan, M., & Jaramillo, A. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.11.004 · Cited by 18
Engineering the Drosophila Genome for Developmental Biology
Korona, D., Koestler, S. A., & Russell, S. R. H. (2017) · Journal of Developmental Biology · doi:10.3390/jdb5040016 · Cited by 18
Gupta, N. R., Susa, K., Yoda, Y., Bonventre, J. V., Valerius, M. T., & Morizane, R. (2018) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.50 · Cited by 18
Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Dictyostelium
Muramoto, T., Iriki, H., Watanabe, J., & Kawata, T. (2019) · Cells · doi:10.3390/cells8010046 · Cited by 19
Data Mining by Pluralistic Approach on CRISPR Gene Editing in Plants
Kaul, T., Raman, N. M., Eswaran, M., Thangaraj, A., Verma, R., Sony, S. K., Sathelly, K., Kaul, R., Yadava, P., & Agrawal, P. K. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00801 · Cited by 18
Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR
Espino-Saldaña, Á. E., Rodríguez-Ortiz, R., Pereida‐Jaramillo, E., & Martínez‐Torres, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191001145550 · Cited by 18
Genome-wide detection and analysis of CRISPR-Cas off-targets
Rodríguez, T., Dadafarin, S., Pratt, H., Liu, P., Amrani, N., & Zhu, L. J. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.012 · Cited by 19
Immunotherapy perspectives in the new era of B-cell editing
Ueda, N., Cahen, M., Danger, Y., Moreaux, J., Sirac, C., & Cogné, M. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003792 · Cited by 19
Advances in Accurate Microbial Genome-Editing CRISPR Technologies
Lee, H. J., & Lee, S. J. (2021) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2106.06056 · Cited by 19
Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations
Choi, E., Hwang, H.-Y., Kwon, E., Kim, D., & Koo, T. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.09.005 · Cited by 18
The oncogenic transcription factor FOXQ1 is a differential regulator of Wnt target genes
Pizzolato, G., Moparthi, L., Söderholm, S., Cantù, C., & Koch, S. (2022) · Journal of Cell Science · doi:10.1242/jcs.260082 · Cited by 18
Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical Trials
Yee, T., & Wert, K. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012375 · Cited by 21
Practical Considerations for Using Pooled Lentiviral CRISPR Libraries
McDade, J. R., Waxmonsky, N. C., Swanson, L. E., & Fan, M. (2016) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.8 · Cited by 18
Brödel, A. K., Jaramillo, A., & Isalan, M. (2017) · Nature Protocols · doi:10.1038/nprot.2017.084 · Cited by 18
CRISPR/Cas9 therapeutics for liver diseases
Aravalli, R. N., & Steer, C. J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26627 · Cited by 19
Huang, D., Liu, Y., Wang, G. A., Lv, S., Tan, Y., & Li, F. (2025) · Chemical Society Reviews · doi:10.1039/d5cs01006c · Cited by 17
Applications of CRISPR-Cas Technologies to Proteomics
Dolgalev, G. V., & Poverennaya, E. V. (2021) · Genes · doi:10.3390/genes12111790 · Cited by 18
Combining CRISPR-Cas9 and brain imaging to study the link from genes to molecules to networks
Marciano, S., Ionescu, T. M., Saw, R. S., Cheong, R. Y., Kirik, D., Maurer, A., Pichler, B. J., & Herfert, K. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122552119 · Cited by 17
A CRISPRi-based genetic resource to study essential Staphylococcus aureus genes
Reed, P., Sorg, M., Alwardt, D., Serra, L., Veiga, H., Schäper, S., & Pinho, M. G. (2023) · mBio · doi:10.1128/mbio.02773-23 · Cited by 17
CRISPR/Cas in Grapevine Genome Editing: The Best Is Yet to Come
Ren, C., Mohamed, M. S. M., Aini, N., Kuang, Y., & Liang, Z. (2024) · Horticulturae · doi:10.3390/horticulturae10090965 · Cited by 18
Recent advances and current status of gene therapy for epilepsy
Cai, A., Gao, K., Zhang, F., & Jiang, Y. (2024) · World Journal of Pediatrics · doi:10.1007/s12519-024-00843-w · Cited by 19
The CRISPR revolution and its impact on cancer research
Kannan, R., & Ventura, A. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14230 · Cited by 17
Geng, Y., Deng, Z., & Sun, Y. (2016) · RSC Advances · doi:10.1039/c6ra02774a · Cited by 17
Ren, X., Holsteens, K., Li, H., Sun, J., Zhang, Y., Liu, L., Liu, Q., & Ni, J. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9029-9 · Cited by 20
CRISPR-based tools for plant genome engineering
Silva, N. V. E., & Patron, N. J. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170011 · Cited by 17
A pipeline for characterization of novel Cas9 orthologs
Karvelis, T., Young, J. K., & Šikšnys, V. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.021 · Cited by 17
A Multiplexed CRISPR/Cas9 Editing System Based on the Endogenous tRNA Processing
Xie, K., & Yang, Y. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8991-1_5 · Cited by 18
Simultaneous targeting of linked loci in mouse embryos using base editing
Lee, H., Willi, M., Smith, H. E., Miller, S. M., Liu, D. R., Liu, C., & Hennighausen, L. G. (2019) · Scientific Reports · doi:10.1038/s41598-018-33533-5 · Cited by 17
Development and Application of CRISPR/Cas System in Rice
Ren, J., Hu, X., Kejian, W., & Wang, C. (2019) · Rice Science · doi:10.1016/j.rsci.2019.01.001 · Cited by 17
Versatile transcription control based on reversible dCas9 binding
Widom, J. R., Rai, V., Rohlman, C. E., & Walter, N. G. (2019) · RNA · doi:10.1261/rna.071613.119 · Cited by 18
Genetically Engineering the Nervous System with CRISPR-Cas
Sandoval, A., Elahi, H., & Ploski, J. E. (2020) · eNeuro · doi:10.1523/eneuro.0419-19.2020 · Cited by 18
Application of CRISPR/Cas system for genome editing in cotton
Fiaz, S., Khan, S. A., Younas, A., Shahzad, K., Ali, H., Noor, M. A., Ashraf, U., & Nadeem, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821910-2.00010-2 · Cited by 17
CALITAS: A CRISPR-Cas-aware ALigner for In silico off-TArget Search
Fennell, T. J., Zhang, D., Isik, M., Wang, T., Gotta, G. M., Wilson, C. J., & Marco, E. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0036 · Cited by 17
Paired dCas9 design as a nucleic acid detection platform for pathogenic strains
Zhang, Y., Wang, Y., Xu, L., Lou, C., Ouyang, Q., & Qian, L. (2021) · Methods · doi:10.1016/j.ymeth.2021.06.003 · Cited by 18
Recent advances in CRISPR technologies for genome editing
Song, M., & Koo, T. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01336-4 · Cited by 18
CRISPR/Cas correction of muscular dystrophies
Zhang, Y., Nishiyama, T., Olson, E. N., & Bassel‐Duby, R. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112844 · Cited by 18
Deciphering Combinatorial Genetics
Wong, A. S. L., Choi, G. C. G., & Lu, T. K. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-120215-034902 · Cited by 17
Guitart, J., Johnson, J. L., & Chien, W. W. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.007 · Cited by 17
CRISPR Guide RNA Validation In Vitro
Grainger, S. J., Lonquich, B., Oon, C. H., Nguyen, N. A., Willert, K., & Traver, D. J. (2016) · Zebrafish · doi:10.1089/zeb.2016.1358 · Cited by 17
Self-citationA universal method for sensitive and cell-free detection of CRISPR-associated nucleases
Cox, K. J., Subramanian, H. K. K., Samaniego, C. C., Franco, E., & Choudhary, A. (2019) · Chemical Science · doi:10.1039/c8sc03426e · Cited by 17
Base editing the mammalian genome
Schatoff, E. M., Zafra, M. P., & Dow, L. E. (2019) · Methods · doi:10.1016/j.ymeth.2019.02.022 · Cited by 20
Developing Non-Human Primate Models of Inherited Retinal Diseases
Seah, I. Y. J., Goh, D., Chan, H. W., & Su, X. (2022) · Genes · doi:10.3390/genes13020344 · Cited by 16
Correcting inborn errors of immunity: From viral mediated gene addition to gene editing
Castiello, M. C., Ferrari, S., & VILLA, A. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101731 · Cited by 16
Joynt, A. T., Kavanagh, E. W., Newby, G. A., Mitchell, S., Eastman, A. C., Paul, K. C., Bowling, A. D., Osorio, D. L., Merlo, C. A., Patel, S. U., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.06.020 · Cited by 16
Hasanzadeh, A., Ebadati, A., Dastanpour, L., Aref, A. R., Zangabad, P. S., Kalbasi, A., Dai, X., Mehta, G., Ghasemi, A., Fatahi, Y., et al. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00102 · Cited by 16
Yuan, Y., Liu, S.-Z., Farhab, M., Lv, M.-Y., Zhang, T., & Cao, S.-X. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01364-5 · Cited by 18
Banda, A., Impomeni, O., Singh, A., Baloch, A. R., Hu, W., & Jaijyan, D. K. (2024) · Vaccines · doi:10.3390/vaccines12060636 · Cited by 16
Salient Features of Endonuclease Platforms for Therapeutic Genome Editing
Certo, M. T., & Morgan, R. A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.21 · Cited by 17
Sansbury, B. M., Wagner, A. M., Nitzan, E., Tarcic, G., & Kmiec, E. B. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0006 · Cited by 16
Versatile Genome Engineering Techniques Advance Human Ocular Disease Researches in Zebrafish
Zheng, S., Han, R., Xiang, L., Zhuang, Y., & Jin, Z. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00075 · Cited by 16
Jyoti, A., Kaushik, S., Srivastava, V. K., Datta, M., Kumar, S., Yugandhar, P., Kothari, S. L., Rai, V., & Jain, A. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.03.010 · Cited by 17
SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity
Cerchione, D. M., Loveluck, K., Tillotson, E. L., Harbinski, F., DaSilva, J., Kelley, C. P., Keston-Smith, E., Fernández, C. A., Myer, V. E., Jayaram, H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231716 · Cited by 16
Li, Z., Wang, X., Xu, D., Wang, D., Wang, D., Dai, X., Wang, Q., Li, Z., Gu, Y., Ouyang, W., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb3350 · Cited by 16
Self-citationBackstrom, J. R., Sheng, J., Wang, M. C., Bernardo‐Colón, A., & Rex, T. S. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.09.001 · Cited by 16
CRISPR/Cas9 from bench to bedside: what clinicians need to know before application?
Li, Z., & Li, C. (2020) · Military Medical Research · doi:10.1186/s40779-020-00292-2 · Cited by 16
Self-citationComputational pipeline for designing guide RNAs for mismatch-CRISPRi
van Gestel, J., Hawkins, J. S., Todor, H., & Gross, C. A. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100521 · Cited by 16
Spasskaya, D. S., Davletshin, A. I., Bachurin, S. S., Tutyaeva, V. V., Garbuz, D. G., & Karpov, D. S. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12469-5 · Cited by 16
Sullivan, N. T., Allen, A. G., Atkins, A., Chung, C.-H., Dampier, W., Nonnemacher, M. R., & Wigdahl, B. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01872 · Cited by 16
A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
Porter, S. N., Levine, R. M., & Pruett‐Miller, S. M. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180022 · Cited by 18
Generation of genetically modified mice using SpCas9-NG engineered nuclease
Fujii, W., Ito, H., Kanke, T., Ikeda, A., Sugiura, K., & Naito, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-49394-5 · Cited by 16
Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy
Mariot, V., & Dumonceaux, J. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.937879 · Cited by 16
In vivo application of base and prime editing to treat inherited retinal diseases
Jo, D. H., Bae, S., Kim, S., Kim, J., & Kim, J. H. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101132 · Cited by 15
Han, Y., Yuan, Z., Zhong, S. L., Xu, H., & Jiang, S. (2023) · Chemical Science · doi:10.1039/d2sc07067g · Cited by 15
Xia, Y., Sun, L., Liang, Z., Guo, Y., Li, J., Tang, D., Huo, Y., & Guo, S. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.143865 · Cited by 15
Zhou, S., Lenk, L. J., Gao, Y., Wang, Y., Zhao, X., Pan, M., Huang, S., Sun, K., Kalds, P., Luo, Q., et al. (2023) · BMC Genomics · doi:10.1186/s12864-023-09409-y · Cited by 15
Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems
Aquino‐Jarquín, G. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103793 · Cited by 15
The immune system of prokaryotes: potential applications and implications for gene editing
Liu, S. M., Liu, H., Wang, X., & Shi, L. (2024) · Biotechnology Journal · doi:10.1002/biot.202300352 · Cited by 16
Base Editors-Mediated Gene Therapy in Hematopoietic Stem Cells for Hematologic Diseases
Zhang, C., Xu, J., Wu, Y., Xu, C., & Xu, P. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10715-5 · Cited by 16
Feng, X., Xu, R., Liao, J., Zhao, J., Zhang, B., Xu, X., Zhao, P., Wang, X., Yao, J., Wang, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47697-4 · Cited by 16
Mesaki, K., Yamamoto, H., Juvet, S., Yeung, J. C., Guan, Z., Akhter, A., Yao, Y., Dickie, C., Mangat, H., Wang, A., et al. (2024) · Human Gene Therapy · doi:10.1089/hum.2023.223 · Cited by 16
Self-citationGene editing as a promising approach for respiratory diseases
Bai, Y., Liu, Y., Su, Z., Ma, Y., Ren, C., Zhao, R., & Ji, H. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104960 · Cited by 15
Targeted mutagenesis of multiple chromosomal regions in microbes
Csörgő, B., Nyerges, Á., & Pál, C. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.05.010 · Cited by 15
Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells
Salisbury-Ruf, C. T., & Larochelle, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030513 · Cited by 15
Lau, M. S. H., Sheng, L., Zhang, Y., & Minton, N. P. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00138 · Cited by 15
Wang, J., Teng, Y., Gong, X., Zhang, J., Wu, Y., Lou, L., Li, M., Xie, Z., & Yan, Y. (2022) · Metabolic Engineering · doi:10.1016/j.ymben.2022.10.005 · Cited by 16
Genome editing with natural and engineered CjCas9 orthologs
Gao, S., Wang, Y., Qi, T., Wei, J., Hu, Z., Liu, J., Sun, S., Liu, H., & Wang, Y. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.01.029 · Cited by 16
Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells
Li, H., Bartke, R., Zhao, L., Verma, Y., Horacek, A., Ben-Natan, A. R., Pangilinan, G. R., Krishnappa, N., Nielsen, R., & Hockemeyer, D. F. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01065-7 · Cited by 16
Single-Base Pair Genome Editing in Human Cells by Using Site-Specific Endonucleases
Ochiai, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921128 · Cited by 15
CRISPR-engineered genome editing for the next generation neurological disease modeling
Feng, W., Liu, H., & Kawauchi, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.019 · Cited by 15
Recent advances in DNA-free editing and precise base editing in plants
Zhang, Y., & Gao, C. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170021 · Cited by 16
Engineering CRISPR-Cas9 RNA–Protein Complexes for Improved Function and Delivery
Rouet, R., de Oñate, L., Li, J., Murthy, N., & Wilson, R. C. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0037 · Cited by 16
CRISPR Takes the Front Seat in CART-Cell Development
Manriquez-Roman, C., Siegler, E. L., & Kenderian, S. S. (2021) · BioDrugs · doi:10.1007/s40259-021-00473-y · Cited by 15
Narra, M., Ray, A., Polley, B., Yang, H., & Bhowmik, P. (2025) · Frontiers in Plant Science · doi:10.3389/fpls.2025.1718810 · Cited by 16
A Decade of CRISPR-Cas Gnome Editing in C. elegans
Kim, H., Hong, Y., & Chen, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415863 · Cited by 14
The application of CRISPR-Cas system in Staphylococcus aureus infection
Wang, J., Liu, F., Long, J., Jin, Y., Chen, S., Duan, G., & Yang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34383 · Cited by 16
Current Knowledge of Base Editing and Prime Editing
Averina, O. A., Kuznetsova, S. A., Permyakov, O. A., & Владимирович, С. П. (2024) · Molecular Biology · doi:10.1134/s0026893324700195 · Cited by 14
Yang, Y., Zheng, Y., Zou, Q., Li, J., & Feng, H. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012340 · Cited by 14
Gene editing in common cardiovascular diseases
Lauerer, A.-M., Caravia, X. M., Maier, L. S., Chemello, F., & Lebek, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108720 · Cited by 15
Yao, J.-Y., Liu, T., Hu, X.-R., Sheng, H., Chen, Z.-H., Zhao, H., Li, X., Wang, Y., & Hao, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117557 · Cited by 14
Marnis, H., & Syahputra, K. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110220 · Cited by 16
Genome editing: A breakthrough in life science and medicine [Review]
Hatada, I., & Horii, T. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0716 · Cited by 14
The Acidaminococcus sp. Cas12a nuclease recognizes GTTV and GCTV as non-canonical PAMs
Jacobsen, T. L., Liao, C., & Beisel, C. L. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz085 · Cited by 15
The Power of Gene Technologies: 1001 Ways to Create a Cell Model
Karagyaur, M. N., Primak, A. L., Efimenko, A. Y., Никитична, С. М., & Va, T. (2022) · Cells · doi:10.3390/cells11203235 · Cited by 14
Enhancing the quality of staple food crops through CRISPR/Cas-mediated site-directed mutagenesis
Adeyinka, O. S., Tabassum, B., Landry, K. B., & Ogungbe, I. V. (2023) · Planta · doi:10.1007/s00425-023-04110-6 · Cited by 16
Partridge, E. C., Watkins, T. A., & Mendenhall, E. M. (2016) · BioEssays · doi:10.1002/bies.201600028 · Cited by 15
Metadata
- Authors
- Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P. W., Li, Z., Peterson, R. T., Yeh, J.-R. J., Aryee, M. J., & Joung, J. K.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Corresponding author
- Joung, J. Keith
- ORCID
- Venue
- Nature
- Published
- 2015-06-22
- Volume
- 523
- Issue
- 7561
- Pages
- 481-485
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4540238
- OpenAlex
- W4245053291
- Semantic Scholar
- afe29e1767b5d0f3563ee9f2c1a586a9d5e8cb9b
- Cited by
- 1,624
- References
- 36
- Citations by year
- 2026: 58 · 2025: 105 · 2024: 117 · 2023: 134 · 2022: 166 · 2021: 165 · 2020: 164 · 2019: 154 · 2018: 147 · 2017: 186 · 2016: 167 · 2015: 58
- FWCI
- 80.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of General Medical Sciences (DP1GM105378, R01GM107427, R01GM088040)
- National Center for Chronic Disease Prevention and Health Promotion (DP1 GM105378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, SpCas9, protospacer adjacent motif, genome editing, off-target effects, SaCas9, Cas9 nickase, zebrafish
- MeSH terms
- Animals, Cell Line, Humans, Mutation, Staphylococcus aureus, Streptococcus pyogenes, Substrate Specificity, Zebrafish, Protein Engineering, Genome, Directed Molecular Evolution, Amino Acid Substitution, Streptococcus thermophilus, Nucleotide Motifs, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
